+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Spirometers - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • October 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4806095
The global market for Spirometers was estimated at US$1.2 Billion in 2023 and is projected to reach US$2.2 Billion by 2030, growing at a CAGR of 8.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Why Is the Demand for Spirometers on the Rise in Healthcare?

Spirometers are essential diagnostic tools in healthcare, used to assess lung function and diagnose respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. With the rising incidence of respiratory diseases worldwide, driven by factors such as air pollution, smoking, and an aging population, the demand for spirometers is growing significantly. These devices are widely used in hospitals, clinics, primary care settings, and home-based care to measure lung capacity, airflow, and other critical parameters. As the focus on early diagnosis, preventive care, and personalized treatment intensifies, the adoption of spirometers is expanding, providing healthcare professionals with valuable insights into patient respiratory health and aiding in the management of chronic respiratory disorders.

How Are Technological Innovations Transforming the Spirometer Market?

Technological advancements in digital, portable, and smartphone-connected spirometers are transforming the spirometer market, offering greater accuracy, convenience, and ease of use for both healthcare providers and patients. The emergence of advanced, AI-powered spirometers with enhanced data analytics capabilities is enabling more precise diagnosis, monitoring, and management of respiratory conditions. Innovations in user-friendly, non-invasive, and wireless spirometer solutions are expanding their application in home-based, remote, and point-of-care settings, supporting telemedicine and remote patient monitoring initiatives. Additionally, the integration of spirometry data with electronic health records (EHRs), cloud-based platforms, and digital health applications is providing healthcare professionals with a comprehensive view of patient health, facilitating better clinical decision-making, and improving patient outcomes.

Which Market Segments Are Leading the Growth of the Spirometer Industry?

Product types include hand-held spirometers, table-top spirometers, and desktop spirometers, with hand-held spirometers holding a large market share due to their portability, ease of use, and suitability for home-based and point-of-care testing. Technology segments comprise flow measurement spirometers, volume measurement spirometers, and peak flow meters, with flow measurement spirometers being a key segment due to their accuracy in measuring lung function parameters. Applications of spirometers span asthma management, COPD management, pulmonary rehabilitation, and occupational health, with COPD management being the leading segment due to the high prevalence of the disease and the need for regular monitoring. End-use sectors include hospitals, clinics, home healthcare, and research institutes, with hospitals leading the market due to the availability of advanced diagnostic facilities and skilled healthcare professionals. Geographically, North America and Europe are the largest markets for spirometers, driven by high healthcare spending, awareness levels, and advanced infrastructure, while Asia-Pacific is expected to witness rapid growth due to increasing healthcare investments and rising prevalence of respiratory diseases.

What Are the Key Drivers of Growth in the Spirometer Market?

The growth in the spirometer market is driven by several factors, including rising incidence of respiratory diseases, technological advancements in digital, portable, and smartphone-connected spirometers, and the increasing focus on early diagnosis and monitoring of chronic obstructive pulmonary disease (COPD). The need to provide accurate, reliable, and non-invasive lung function testing for various respiratory conditions is driving the demand for spirometers across multiple healthcare settings. Technological innovations in AI-powered spirometers, cloud integration, EHR compatibility, and remote patient monitoring, coupled with advancements in data analytics, sensor technology, and digital health platforms, are enhancing the capabilities, accessibility, and marketability of spirometers, supporting market growth. The expansion of spirometer applications in asthma management, pulmonary rehabilitation, clinical trials, and occupational health, along with the growing emphasis on home-based care, telemedicine, and personalized medicine, is creating new opportunities for market players. Additionally, the focus on developing user-friendly, wireless, and AI-enabled spirometer solutions for diverse healthcare environments is further propelling the growth of the spirometer market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Tabletop Spirometers segment, which is expected to reach US$1.0 Billion by 2030 with a CAGR of a 8.5%. The Handheld Spirometers segment is also set to grow at 7.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was valued at $335.3 Million in 2023, and China, forecasted to grow at an impressive 8.2% CAGR to reach $342.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Spirometers Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Spirometers Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Spirometers Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Chest M.I., Inc., Fukuda Sangyo Co., Ltd., Hill-Rom Holdings, Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 11 Featured):

  • Chest M.I., Inc.
  • Fukuda Sangyo Co., Ltd.
  • Hill-Rom Holdings, Inc.
  • Medical International Research (MIR)
  • MGC Diagnostics Corporation
  • Midmark Corporation
  • ndd Medizintechnik AG
  • Schiller AG
  • Vitalograph Inc.
  • Vyaire Medical, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Spirometers - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Respiratory Diseases and Lung Disorders Drives Spirometer Market Growth
  • Increasing Focus on Early Diagnosis and Monitoring of Chronic Obstructive Pulmonary Disease (COPD) Spurs Adoption
  • Technological Advancements in Digital, Portable, and Smartphone-Connected Spirometers Propel Market Innovation
  • Growing Emphasis on Home-Based, Remote, and Point-of-Care Respiratory Testing Expands Addressable Market Opportunity
  • Emergence of Advanced, AI-Powered Spirometers with Enhanced Data Analytics Capabilities Strengthens Business Case
  • Rising Use of Spirometers in Clinical Trials, Pulmonary Rehabilitation, and Occupational Health Accelerates Market Demand
  • Focus on Developing User-Friendly, Non-Invasive, and Wireless Spirometer Solutions Drives Market Competitiveness
  • Increasing Application of Spirometers in Asthma Management, Allergies, and Smoking Cessation Programs Fuels Market Expansion
  • Expansion of Spirometer Applications in Sports Medicine, Military, and Research Sectors Spurs Market Potential
  • Shift Towards Digital Health Platforms, Cloud Integration, and EHR Compatibility for Spirometry Data Expands Market Opportunities
  • Increasing Emphasis on Personalized Medicine, Telemedicine, and Remote Patient Monitoring Creates New Opportunities
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Spirometers Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Spirometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Spirometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Spirometers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Tabletop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Tabletop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Tabletop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Handheld by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Handheld by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Handheld by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Desktop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Desktop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Desktop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Volume Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Volume Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Volume Measurement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Peak Flow Meter (PFM) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Peak Flow Meter (PFM) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Peak Flow Meter (PFM) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Flow Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Flow Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Flow Measurement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for COPD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: World 16-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 29: World Recent Past, Current & Future Analysis for Pulmonary Fibrosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 30: World Historic Review for Pulmonary Fibrosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: World 16-Year Perspective for Pulmonary Fibrosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 32: World Recent Past, Current & Future Analysis for Cystic Fibrosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 33: World Historic Review for Cystic Fibrosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: World 16-Year Perspective for Cystic Fibrosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Spirometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Spirometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Spirometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Spirometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Spirometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Spirometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Spirometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Spirometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Chest M.I., Inc.
  • Fukuda Sangyo Co., Ltd.
  • Hill-Rom Holdings, Inc.
  • Medical International Research (MIR)
  • MGC Diagnostics Corporation
  • Midmark Corporation
  • ndd Medizintechnik AG
  • Schiller AG
  • Vitalograph Inc.
  • Vyaire Medical, Inc.

Table Information